Product Name: PLCG2 (756-762) pY759
Product Number: PE-04ADH99
Size: | 200 µg | | Price: | 47.00 |
| 1 mg | | $US | 94.00 |
| 5 mg | | | 206.00 |
Peptide Name: PLCG2 (756-762) pY759
Product Use: Services as a blocking peptide for use with the PLCG2-pY759 rabbit polyclonal antibody (Cat. No.: AB-PN531) that is also available from Kinexus. This phosphopeptide may also be useful as a substrate for screening the phosphatase activity of protein phosphatases. The peptide sequence is located near the end of the second SH2 domain in the protein. One of the major in vivo phosphorylation sites in PLCG2. Y759 phosphorylation stimulates phospholipase activity, and regulates molecular association, including inducing interaction with Lyn.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: SRM-pY-VDP
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: βAla-Cys
Peptide Modifications Other: Phosphorylated
Peptide Molecular Mass Calculated: 1121.17 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: PLCG2 - pY759 phosphosite-specific antibody (Cat. No.: AB-PN531) Scientific Background: PLCG2 mediates the production of the second messenger molecules diacylglycerol (DAG) and 1D-myo-inositol 1,4,5-trisphosphate (IP3) from the hydrolysis of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate. It becomes activated in response to ligand-mediated activation of receptor-type receptor-tyrosine kinases and is calcium-activated.